Current foundation models outperform trainees on text questions but struggle with multimodal ophthalmic imaging ...

D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response to therapy, today announced its participation as an exploratory ...

Objectives Understanding the molecular changes in the preclinical synovium is crucial for identifying factors that drive ...